Clinical Trials Logo

Clinical Trial Summary

This multicenter, randomized, single-blind study assessed the safety and efficacy of Protescal for the reduction of post-operative adhesion formation following myomectomy.


Clinical Trial Description

The age of the patients participating in the study overed 20 years and included nonpregnant women requiring laparoscopic myomectomy and expected to undergo a second-look laparoscopy as part of their treatment plan 5 weeks after the initial surgery. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01810900
Study type Interventional
Source LG Life Sciences
Contact
Status Terminated
Phase Phase 3
Start date September 2012
Completion date December 2013

See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Completed NCT00624390 - Sepraspray™ Laparoscopic Myomectomy Study N/A
Terminated NCT03935815 - Quadratus Lumborum Nerve Blocks for Myomectomies Phase 1
Completed NCT01530802 - Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy N/A
Recruiting NCT05154279 - The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations N/A
Terminated NCT00672750 - A Retrospective Review Of Outcomes Following Laparoscopic Myomectomy N/A